We studied the dynamics of lipid peroxidation—antioxidant defense system in rat model of alloxan diabetes and compared it with disorders of carbohydrate and lipid metabolism. It was found that rats not treated with insulin developed hyperglycemia, hypertriglyceridemia, hypocholesterolemia, and hypotocoferolemia with simultaneous accumulation of circulating LPO products 96 h after the administration of alloxan. The severity of hyperglycemia and hypertriglyceridemia decreased, hypercholesterolemia developed, hypotocoferolemia returned to normal, and the tendency to LPO inhibition was observed in rats 10 days after alloxan admi nistration against the background of previous one-week treatment with insulin. In 17 days after the induction of alloxan diabetes preceded by two-week insulin therapy, the content of lipoperoxides reduced below the normal values with simultaneous progression of hypercholesterolemia, hypertriglyceridemia and the increase in serum fructosamine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. I. Balabolkin, E. M. Klebanova, and V. M. Kreminskaya, Treatment of Diabetes and its Complications [in Russian], Мoscow (2005).
I. A. Volchegorskii, V. E. Tseylikman, O. L. Kolesnikov, et al., Probl. Endocrinol., No. 6, 38–42 (1995).
I. A. Volchegorskii, M. G. Moskvicheva, and E. N. Chashchina, Zh. Nevrol. Psikhiatr., 105, No. 2, 41–45 (2005).
I. A. Volchegorskii, V. E. Tseylikman, and O. B. Tseylikman, Vestn. Ross. Akad. Med. Nauk, No. 8, 21–25 (2005).
I. A. Volchegorskii, N. V. Tishevskaya, and E. V. Dementieva, Eksp. Klin. Farmakol., 71, No. 6, 23–27 (2008).
I. A. Volchegorskii, M. N. Alekseyev, M. I. Volchegorskaya, and L. M. Rassokhina, Klin. Med., No. 10, 52–59 (2008).
I. A. Volchegorskii, L. M. Rassokhina, I. Yu. Miroshnichenko, et al., Bull. Exp. Biol. Med., 150, No. 3, 327–332 (2011).
I. I. Dedov and M. A. Shestakova, Algorithms of Specialized Medical Care to Patients with Diabetes Mellitus [in Russian], Мoscow (2009).
L. M. Dobordzhginidze and N. A. Gratsianskiy, Sakharnyy Diabet, No. 2, 41–48 (2001).
R. A. Kopaladze, Uspekhi Fiziol. Nauk, 29, No. 4, 74–92 (1998).
E. B. Menshchikova, N. K. Zenkov, V. Z. Lankin, et al., Oxidative Stress. Pathological States and Diseases [in Russian], Novosibirsk (2008).
N. Dicter, Z. Madar, and O. Tirosh, J. Nutr., 132, No. 10, 3001–3006 (2002).
S. Lenzen, Diabetologia, 51, No. 2, 216–226 (2008).
R. Srivatsan, S. Das, G. Gadde, et al., Arch. Iranian Med., 12, No. 2, 121–127 (2009).
J. R. Williamson and Y. Ido, Invest. Ophthalmol. Vis. Sci., 39, No. 7, 1295–1296 (1998).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 1, pp. 31–35, January, 2013
Rights and permissions
About this article
Cite this article
Volchegorskii, I.A., Rassokhina, L.M. & Miroshnichenko, I.Y. Dynamics of Lipid Peroxidation—Antioxidant Defense System during Alloxan Diabetes in Rats. Bull Exp Biol Med 155, 26–29 (2013). https://doi.org/10.1007/s10517-013-2071-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-013-2071-y